Brief: Oncology Company TransCode Therapeutics Appoints Former Alopexx Exec Daniel Vlock As CMO
28/03/2024 15:07
March 28 (Reuters) - Transcode Therapeutics Inc
RNAZ.O :
* TRANSCODE THERAPEUTICS ANNOUNCES APPOINTMENT OF DANIEL
VLOCK,
M.D., AS CHIEF MEDICAL OFFICER
Source text for Eikon: ID:nGNX5DyPkf
Further company coverage: RNAZ.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Transcode Therapeutics
See all newsBrief: TransCode Therapeutics Appoints John Tattory As Interim CFO
Brief: Transcode Therapeutics Appoints Dr. Anna Moore As Chair Of Scientific Advisory Board
Brief: Transcode Therapeutics Inc - Enters Exclusive License Agreement With Unleash
Brief: Transcode Therapeutics Ttx-Mc138 Phase 2A Clinical Trial Expected In First Half Of 2026
Brief: Transcode Therapeutics Expands Leadership With Appointment Of Jack E. Stover To Board Of Directors